Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1070 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2025-03-31 (jdsupra.com)
Securities Litigation Against Life Sciences Companies 2024 Year in Review | Goodwin - JDSupra
Welcome to our ninth annual report on US securities class actions filed against publicly traded life sciences companies, which include pharmaceutical,...
Read more
2025-03-24 (braziljournal.com)
Funds question BNDESPAR and PREVI proposal to change Tupy CEO -
Managers 4th investments, Organon Capital, Charles River and Real Investor, who together add up to almost 10% of Tupy's shares, are concerned about the decision
Read more
2022-08-23 (dailyherald.com)
Charles River Laboratories Expands Contract Vivarium Space on West Coast
August 23, 2022 at 08:00 AM EDT Turnkey research facility expands network in San Diego, San Francisco, Thousand Oaks and Seattle Charles River Laboratories International, Inc.( NYSE: CRL) today announced the addition of five Charles River Accelerator
Read more
2022-08-23 (businesswire.com)
Charles River Laboratories Expands Contract Vivarium Space on West Coast
Charles River announces the addition of five CRADL locations, expanding operations to 27 vivarium facilities in key biohubs.
Read more
2022-04-10 (wilmingtonapple.com)
Wilmington’s Charles River Laboratories Acquires Explora BioLabs
The deal adds more than 15 Vivarium facilities across 3 key U.S. biohubs.
Read more